Pelvic Floor Electric Stimulator Market (2026 - 2033)

Pelvic Floor Electric Stimulator Market Summary

The global pelvic floor electric stimulator market size was valued at USD 1.0 billion in 2025 and is projected to grow from USD 1.1 billion in 2026 to USD 1.9 billion in 2033, at a CAGR of 9.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 38.0% in 2025. The high prevalence of Urinary Incontinence (UI), increasing awareness initiatives by various government & non-profit organizations, and rising technological investments are the most significant market growth drivers. 

In addition, the rising prevalence of neurodegenerative disorders, the growing geriatric population, the rising demand for home healthcare, and the increasing use of medical sensors in various treatments are further expected to boost market growth. A pelvic floor electrical stimulator delivers neuromuscular electrical stimulation to the pelvic floor to strengthen the pelvic floor muscles.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

It is delivered generally by anal or vaginal probes connected to an external pulse generator. The method of pelvic floor electrical stimulation varies according to parameters such as stimulus frequency (Hz), amplitude (mA), stimulus intensity, number of treatment days per week, length of each treatment session, location, and clinic or home setting. This device is recommended for patients suffering from urologic disorders, such as urinary retention, cystitis, benign prostatic hyperplasia, and kidney stones. Doctors primarily recommend this product to patients with urinary issues. Moreover, a rapid rise in the geriatric population is a key factor driving increased product demand, as they are at higher risk of UI.

According to the American Society of Nephrology, urologic issues are the third most common type of complaint among patients aged 65 years and older and account for at least part of 47.0% of office visits. Similarly, according to the International Continence Society (ICS), urinary incontinence affects approximately 200 million people worldwide. Moreover, the growing elderly population in the Asia-Pacific region, particularly in countries such as Japan, India, and China, is expected to drive market growth during the forecast period. According to the Japanese government’s 2025 White Paper on Aging Society, the population aged 65 and above has reached 36.24 million, accounting for 29.3% of Japan’s total population. Thus, an increasing number of patients suffering from urinary incontinence is anticipated to boost demand for pelvic floor electrical stimulators, contributing to market growth over the forecast period.

Furthermore, initiatives to increase awareness are expected to boost market growth. For instance, the Australian government has launched the Continence Aids Payment Scheme (CAPS). This scheme supports patients with permanent or severe incontinence by addressing their incontinence needs. They also launched the National Continence Management Program, which aims to raise awareness regarding various bowel and bladder health problems. In addition, professionals, such as urogynecologists, urologists, gynecologists, and nurses, as well as many professional organizations, have actively participated in promoting awareness about continence in all care settings. For instance, the International Continence Society (ICS) established the Continence Promotion Committee (CPC) to promote education, services, and public awareness programs on incontinence worldwide.

Thus, the growing number of awareness programs regarding urinary diseases and the rising prevalence of UI, organized by various government and non-profit organizations, are among the factors driving market growth. Countries such as the U.S. and Canada have witnessed a high prevalence rate of UI among the elderly population. In this region, UI has a high prevalence and is discussed more openly in the media, including newspapers and television commercials. According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), benign prostatic hyperplasia affects nearly 5.0%-6.0% of men aged 40-64 years and more than 30.0% of men aged 65 years and older in the U.S. This condition may occur due to trauma or injury to the penis, urethra, or bladder and is associated with pregnancy.

Similarly, according to the Canadian Cancer Society’s Canadian Cancer Statistics 2025, bladder cancer remains one of the most common cancers in Canada, with approximately 12,600 new cases projected in 2025. These factors are expected to boost the product demand. Furthermore, the rising prevalence of hypertension and diabetes is one of the major factors for the increasing prevalence of urinary incontinence, which in turn is driving the market. According to the WHO, around 1.4 billion adults aged 30-79 years had hypertension in 2024, which represents 33.0% of the population. Diabetes is the primary cause of advanced renal failure, followed by hypertension, which is estimated to affect around 1.0 billion individuals globally. Thus, the increasing number of patients suffering from end-stage renal diseases is anticipated to boost product demand, thereby boosting market growth over the forecast period.

Analyst Perspective

The pelvic floor electrical stimulation market is expected to grow significantly, driven by the rising global burden of urinary incontinence (UI), benign prostatic hyperplasia (BPH), urinary retention, and other urological disorders. An inclination toward non-invasive procedures among patients and cost-effective operations among care providers are primarily driving greater adoption of pelvic floor electrical stimulators as an effective therapeutic measure. Changing dynamics of the healthcare industry, including an increase in home healthcare and a demand for efficient home-based treatment solutions, along with advancements in portable and user-friendly stimulation devices, are also contributing to growth. In addition, government-led awareness initiatives are improving early detection of diseases, encouraging patients to seek treatment for conditions that have historically been underreported due to social stigma. Key companies in this market have been investing in innovation, R&D, new product developments, and acquisitions to improve their market presence.

Application Insights

The UI segment dominated the market with an 84.0% share in 2025, owing to the high prevalence of stress & urge incontinence and various product launches by key players. The geriatric population and pregnant women are more prone to UI. According to a study published in NCBI, the prevalence of UI in pregnant women ranges from 32.00% to 64.00%. In addition, as per the Office on Women’s Health (U.S. Department of Health and Human Services), around 4 in 10 women get some type of UI during pregnancy.

This is expected to boost growth in this segment. However, the sexual dysfunction segment is expected to grow at the highest CAGR from 2025 to 2033. Products introduced by the top players in the market, increasing awareness about the treatment of sexual dysfunction through pelvic floor electric stimulators, and the rising prevalence of sexual dysfunction are a few factors that may drive market growth in the future. For instance, according to the University of Wisconsin Foundation (School of Medicine and Public Health), around 5% of men aged above 40 years have Erectile Dysfunction (ED).

Regional Insights

North America dominated the market with a 38.0% share in 2025. This dominance can be attributed to factors such as the increasing incidence of neurodegenerative disorders, the rising geriatric population, the increasing prevalence of sexual dysfunction, and the presence of many players in this region. According to the Parkinson’s Foundation, around 60,000 people in the U.S. are diagnosed with Parkinson’s disease every year. According to a report by the U.S. Census Bureau, around 78.0 million people will be aged 65 and older by 2035. In addition, according to the Alzheimer Society Canada, around 25,000 new cases of Alzheimer’s disease are diagnosed every year, and it is expected to increase to 9, 37,000 by 2031.

To learn more about this report, Download Free Sample Report

Asia Pacific Pelvic Floor Electric Stimulator Market Trends

The pelvic floor electric stimulator market in the Asia Pacific is expected to lead the market from 2025 to 2033, owing to various factors, such as increasing government spending, increasing investments by key players, and awareness programs by various organizations. For instance, in India, the Urological Society of India drafted guidelines to raise awareness of urinary incontinence. Similarly, the Korean Incontinence Society in South Korea is working to raise awareness of urology issues related to the pelvic floor and lower urinary tract.

Key Pelvic Floor Electric Stimulator Companies

Key companies launch new products to strengthen their portfolios and offer diverse, technologically advanced & innovative offerings to their customers. It is the most prominently adopted strategy by companies for attracting more customers. Moreover, several players engage in mergers and acquisitions to strengthen their industry position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies. Players, such as Laborie, Inc. and Athena Feminine Technologies, Inc., are using these strategies to gain more market share. For instance, in January 2026, Laborie Medical Technologies acquired the JADA System from Organon. This has added an FDA-cleared device, JADA, designed to improve the control and treatment of abnormal postpartum uterine bleeding, to Laborie’s portfolio. The transaction, which is valued at up to USD 465 million, expands Laborie’s portfolio in women's health and obstetrics. The company aims to strengthen its position in medical technology while broadening its portfolio of innovative therapeutic solutions.

Key Pelvic Floor Electric Stimulator Companies

The following key companies have been profiled for this study on the pelvic floor electric stimulator market.

• Altivera Medical, Inc.

• TensCare Ltd.

• NeuroTrac

• INCONTROL CARE

• Prometheus Group

• Laborie

• Athena Feminine Technologies, Inc.

• Atlantic Health

• Renovia

Recent Developments

• In April 2026, ANEUVO announced that it had received U.S. FDA clearance for the ExaStim Stimulation System (“ExaStim”), a non-invasive neuromodulation platform designed for personalized transcutaneous spinal cord stimulation delivery in both home and clinic settings.

• In October 2025, NeuroGyn announced that the PosStim pelvic neurostimulator had reached the design freeze stage. Designed for Genital Nerve Stimulation (GNS), the project is now under transition from the R&D phase to clinical validation. 

Global Pelvic Floor Electric Stimulator Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pelvic floor electric stimulator market report based on application, region:

To learn more about this report, Download Free Sample Report

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Urinary Incontinence

  • Neurodegenerative Disorders

  • Sexual Dysfunction

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait